|
VPS52 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.791000E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.167500E-04 |
| Normal-vs-Stage2 |
6.640800E-01 |
| Normal-vs-Stage3 |
2.15299999999363E-05 |
| Normal-vs-Stage4 |
9.683100E-03 |
| Stage1-vs-Stage2 |
8.501300E-03 |
| Stage1-vs-Stage3 |
3.917500E-02 |
| Stage1-vs-Stage4 |
9.471800E-01 |
| Stage2-vs-Stage3 |
5.794500E-04 |
| Stage2-vs-Stage4 |
5.592000E-02 |
| Stage3-vs-Stage4 |
1.560390E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.355200E-04 |
| Normal-vs-AfricanAmerican |
2.889400E-01 |
| Normal-vs-Asian |
3.793800E-02 |
| Caucasian-vs-AfricanAmerican |
1.856220E-01 |
| Caucasian-vs-Asian |
1.826810E-01 |
| AfricanAmerican-vs-Asian |
6.590400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.303700E-02 |
| Normal-vs-Female |
1.593090E-04 |
| Male-vs-Female |
2.329000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.350700E-04 |
| Normal-vs-Age(41-60Yrs) |
2.697000E-03 |
| Normal-vs-Age(61-80Yrs) |
1.256100E-03 |
| Normal-vs-Age(81-100Yrs) |
4.622600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.560000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.219800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.312000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.063200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.394000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.735200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.904560E-03 |
| Classical-VS-Follicular |
8.592400E-01 |
| Classical-VS-Other |
3.531600E-01 |
| Classical-VS-Normal |
2.784000E-03 |
| Tall-VS-Follicular |
3.079200E-03 |
| Tall-VS-Other |
4.535000E-01 |
| Tall-VS-Normal |
2.54970000002075E-06 |
| Follicular-VS-Other |
4.194600E-01 |
| Follicular-VS-Normal |
3.462400E-02 |
| Other-VS-Normal |
3.616400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.522900E-03 |
| Normal-vs-N1 |
2.978000E-04 |
| N0-vs-N1 |
9.947700E-02 |
|
|
